Baker Bros. Advisors’s Fate Therapeutics FATE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-2,485,018
Closed -$2.78M 93
2025
Q2
$2.78M Sell
2,485,018
-773,384
-24% -$899K 0.03% 72
2025
Q1
$2.57M Hold
3,258,402
0.03% 71
2024
Q4
$5.38M Buy
3,258,402
+260,630
+9% +$657K 0.06% 66
2024
Q3
$10.5M Hold
2,997,772
0.11% 51
2024
Q2
$9.83M Buy
2,997,772
+1,179,591
+65% +$5.16M 0.13% 48
2024
Q1
$13.3M Buy
+1,818,181
New +$11.3M 0.17% 44
2023
Q3
Sell
-1,671,717
Closed -$7.96M 103
2023
Q2
$7.96M Hold
1,671,717
0.05% 63
2023
Q1
$9.53M Buy
1,671,717
+1,456,022
+675% +$8.79M 0.05% 55
2022
Q4
$2.18M Hold
215,695
0.01% 97
2022
Q3
$4.83M Buy
+215,695
New +$6.23M 0.03% 82

Other funds holding FATE